Hideyuki Koharazawa

622 total citations
40 papers, 405 citations indexed

About

Hideyuki Koharazawa is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Hideyuki Koharazawa has authored 40 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 16 papers in Pathology and Forensic Medicine and 12 papers in Oncology. Recurrent topics in Hideyuki Koharazawa's work include Lymphoma Diagnosis and Treatment (14 papers), Acute Myeloid Leukemia Research (13 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Hideyuki Koharazawa is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Acute Myeloid Leukemia Research (13 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Hideyuki Koharazawa collaborates with scholars based in Japan and United States. Hideyuki Koharazawa's co-authors include Heiwa Kanamori, Yoshiaki Ishigatsubo, Shin Fujisawa, Katsumichi Fujimaki, Rika Sakai, Jun Taguchi, Hiroyuki Fujita, Naoto Tomita, Fumio Kodama and Etsuko Yamazaki and has published in prestigious journals such as Blood, British Journal of Haematology and Cancer Science.

In The Last Decade

Hideyuki Koharazawa

38 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideyuki Koharazawa Japan	12	191	115	96	80	52	40	405
Abraham Avigdor Israel	10	111 0.6×	133 1.2×	168 1.8×	76 0.9×	52 1.0×	14	426
Bülent Ündar Türkiye	12	215 1.1×	109 0.9×	49 0.5×	101 1.3×	37 0.7×	51	407
Roswitha Dickerhoff Germany	12	245 1.3×	114 1.0×	155 1.6×	96 1.2×	174 3.3×	37	556
Frank T. Ward United States	8	84 0.4×	131 1.1×	161 1.7×	197 2.5×	59 1.1×	13	429
Sudha Parasuraman United States	8	96 0.5×	102 0.9×	78 0.8×	69 0.9×	75 1.4×	15	304
Hiroshi Harano Japan	11	131 0.7×	44 0.4×	79 0.8×	93 1.2×	25 0.5×	38	351
Tzung‐Chih Tang Taiwan	14	216 1.1×	146 1.3×	197 2.1×	111 1.4×	46 0.9×	33	507
E D Thomas United States	9	151 0.8×	81 0.7×	77 0.8×	83 1.0×	57 1.1×	13	379
Jessica A B van Nies Netherlands	16	201 1.1×	46 0.4×	91 0.9×	78 1.0×	37 0.7×	17	832
Annalisa Serra Italy	14	134 0.7×	80 0.7×	52 0.5×	86 1.1×	102 2.0×	47	520

Countries citing papers authored by Hideyuki Koharazawa

Since Specialization

Citations

This map shows the geographic impact of Hideyuki Koharazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Koharazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Koharazawa more than expected).

Fields of papers citing papers by Hideyuki Koharazawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Koharazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Koharazawa. The network helps show where Hideyuki Koharazawa may publish in the future.

Co-authorship network of co-authors of Hideyuki Koharazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Koharazawa. A scholar is included among the top collaborators of Hideyuki Koharazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Koharazawa. Hideyuki Koharazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Hiroyuki, Rika Sakai, Yoshimi Ishii, et al.. (2020). Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study. Indian Journal of Hematology and Blood Transfusion. 37(1). 60–66. 4 indexed citations

Fujisawa, Shin, Yoshimi Ishii, Kenji Motohashi, et al.. (2019). Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia. International Journal of Hematology. 109(6). 673–683. 12 indexed citations

Yamazaki, Etsuko, Yoshimi Ishii, Wataru Yamamoto, et al.. (2017). Body mass index is a prognostic factor in adult patients with acute myeloid leukemia. International Journal of Hematology. 105(5). 623–630. 10 indexed citations

Tachibana, Takayoshi, Masatsugu Tanaka, Maki Hagihara, et al.. (2015). Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia. International Journal of Hematology. 102(4). 451–459. 1 indexed citations

Yamamoto, Eri, Naoto Tomita, Seiji Sakata, et al.. (2013). MIB‐1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy. Cancer Science. 104(12). 1670–1674. 12 indexed citations

Tomita, Naoto, Hirotaka Takasaki, Shin Fujisawa, et al.. (2013). Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma. Journal of Clinical and Experimental Hematopathology. 53(2). 121–125. 11 indexed citations

Miyazaki, Takuya, Hiroyuki Fujita, Katsumichi Fujimaki, et al.. (2012). Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia. Leukemia Research. 36(8). 998–1003. 26 indexed citations

Tomita, Naoto, Hideyuki Koharazawa, Katsumichi Fujimaki, et al.. (2012). Phase II study of CHOP-GR therapy in diffuse large B-cell lymphoma. International Journal of Hematology. 96(2). 241–246. 2 indexed citations

Koharazawa, Hideyuki, Heiwa Kanamori, Rika Sakai, et al.. (2008). Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia. Leukemia & lymphoma. 49(11). 2133–2140. 3 indexed citations

10.

Miyazaki, Takuya, Jun Taguchi, Takashi Obana, et al.. (2006). [Multiple myeloma presenting as cavernous sinus syndrome].. PubMed. 47(10). 1393–5. 2 indexed citations

11.

Tomita, Naoto, Fumio Kodama, Chizuko Hashimoto, et al.. (2006). Phase II study of CHOP-GR therapy for advanced-stage follicular lymphoma. Leukemia & lymphoma. 47(6). 1041–1047. 3 indexed citations

12.

Takasaki, Hirotaka, Heiwa Kanamori, Satoshi Yamaji, et al.. (2006). Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia. American Journal of Hematology. 81(6). 439–442. 15 indexed citations

13.

Kanamori, Heiwa, Hirotaka Takasaki, Satoshi Yamaji, et al.. (2005). A possible association between the presence of interleukin-4–secreting cells and a reduction in the risk of acute graft-versus-host disease. Experimental Hematology. 33(2). 251–257. 6 indexed citations

14.

Fujimaki, Katsumichi, Hirotaka Takasaki, Hideyuki Koharazawa, et al.. (2005). Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia. Leukemia & lymphoma. 46(7). 1101–1102. 11 indexed citations

15.

Kanamori, Heiwa, Hirotaka Takasaki, Satoshi Yamaji, et al.. (2004). Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia. Anti-Cancer Drugs. 15(7). 729–731. 2 indexed citations

16.

Maruta, A, Minoru Yoshida, Rika Sakai, et al.. (2001). Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplantation. 27(3). 307–310. 72 indexed citations

17.

Kanamori, Heiwa, Hiroshi Tanaka, Satoshi Yamaji, et al.. (2001). Bronchiolitis obliterans organizing pneumonia (BOOP) with suspected liver graft-versus-host disease after allogeneic bone marrow transplantation. Transplant International. 14(4). 266–269. 8 indexed citations

18.

Kanamori, Heiwa, Masatsugu Tanaka, Satoshi Yamaji, et al.. (2001). Bronchiolitis obliterans organizing pneumonia (BOOP) with suspected liver graft-versus-host disease after allogeneic bone marrow transplantation. Transplant International. 14(4). 266–269. 9 indexed citations

19.

Tanaka, Masatsugu, Heiwa Kanamori, Satoshi Yamaji, et al.. (1999). Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome. Anti-Cancer Drugs. 10(3). 289–291. 5 indexed citations

20.

Kanamori, Heiwa, A Maruta, Sho Sasaki, et al.. (1998). Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy. Bone Marrow Transplantation. 21(7). 705–709. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact